Dmitriy Molchanov
Lawyers
Associate in our Mergers & Acquisitions practice. Previously completed a rotation in Capital Markets.
Experience highlights
Recent Representations
- Gilead Sciences $4.3 billion acquisition of CymaBay Therapeutics
- Atairos investment in V Sports
- Summit Materials $3.2 billion combination with Argos USA
- Roper Technologies $1.25 billion acquisition of Syntellis Performance Solutions
- Natura $2.525 billion sale of Aesop to L’Oréal
- Arco Platform acquisition of isaac
- Emerson $3 billion sale of InSinkErator business to Whirlpool
- Industrial Media acquisition by Sony Pictures Television
- BDT Capital Partners acquires a majority interest in MJH Life Sciences
- Chosen Foods investment by Butterfly Equity
- Novo Nordisk acquisition of Neotope Neuroscience
- Loews adds GIC as a partner in Altium Packaging
- Crowdstrike $400 million acquisition of Humio
- KPS Capital Partners $2.1 billion acquisition of assets of Garrett Motion
- Applied Therapeutics, Inc. Initial Public Offering
- Davis Polk Advises Marsh & McLennan Companies, Inc. on Its $250 Million Notes Reopening
Education
J.D., University of Pennsylvania Law School
- Senior Editor, University of Pennsylvania Law Review
M.B.A., University of Pennsylvania, Wharton School
B.A., Political Science, Carleton College
Professional history
- Davis Polk since 2017
Qualifications and admissions
- State of New York